Skip to main content

Acute Heart Failure syndrome made simple

  • Acute heart failure syndrome (AHFS) spectrum can be divided into 5 groups as regards therapeutic management: 
    • (i) Dyspnoea + /- congestion with elevated systolic blood pressure (SBP)>140 mmHg, usually with abrupt onset (acute pulmonary oedema) APO (most frequent type)
    • (ii) Dyspnoea + /- congestion with normal SBP 100-140 mmHg, usually with gradual onset predominant systemic oedema and milder APO
    • (iii) Dyspnoea + /- congestion with low SBP <100 mmHg, with predominant cardiogenic shock or end-stage cardiac failure (most fatal type)
    • (iv) Dyspnoea + /- congestion with signs of ACS such as chest pain
    • (v) Isolated RV failure usually without APO.

  • Treatment aims

    • Decrease left ventricular diastolic pressure, by decreasing systemic vascular resistance and improving systolic and diastolic functional reserve.
    • Promote coronary blood flow.
    • Correct acute respiratory failure.
    • In-hospital mortality for APO is up to 12%, with one-year mortality up to 40%.

  • Drugs

    • Nitroglycerin S/L, topical or IV titrated to avoid hypotension.
      • Most rapidly venodilates, reduces LV afterload and corrects myocardial ischaemia. Ideal for AHFS type 1. (i) above.
      • Also consider in AHFS types 1. (ii) and (iv) if SBP > 110 mmHg.
      • Avoid in AHFS type 1. (iii) above.
      • Nitrates are used less often than frusemide + were used in just 27% of the patients admitted in the ADHERE registry (USA, 2003)

    • Frusemide IV.  Despite universal use, absolute efficacy is unclear. May cause decrease in cardiac output and increase PVR, plus increase PAOP in more chronic HF. Ideal for AHFS type 1. (ii) above.

    • ACE inhibitor IV, orally or SC also reduces pre- and afterload, but little data in acute situation. Precipitous hypotension is hard to reverse, so use is best reserved for longer term management of HF.

    • Morphine has relatively ineffective / unproven acute venodilating and sympatholytic effects, is rarely used (3% one study) and may result in respiratory depression in face of NIV and/or a poorer outcome. May have role in APO with diastolic dysfunction (ie. EF >40%) with elevated SBP.

    • Traditional inotropic support is with dobutamine, dopamine, milrinone, enoximone or salbutamol for AHFS type 1. (iii) above, but may disastrously increase myocardial oxygen demand, especially in ACS with AHFS type 1. see (iv) above. Rarely need to add vasoconstrictor noradrenaline.
Labels:

Comments

Post a Comment

Popular posts from this blog

power injectable peripherally inserted central catheters

Clinical experience with power injectable peripherally inserted central catheters in intensive care patients     Introduction In intensive care units (ICU), peripherally inserted central catheters (PICC) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome by the use of power-injectable catheters . Method We have retrospectively reviewed all the power injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. Results We have collected 89 power injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related blood stream infection. Non-infective complications ...
1 comment
Read more

The 12 decision making steps for post dural puncture headache treatment

Treatment decision-making algorithm for postdural puncture headache. 1. When diagnosis is made, all patients should receive supportive measures (reassurance, bed rest, analgesics, hydration, quiet environment). 2. Severity of symptoms should be classified using VAS scale (mild 1–3, moderate 4–6, severe 7–10). 3. Virtually all patients will improve in time even without additional therapy. (dashed lines) 4. Symptoms worsen or fail to resolve within 5 days. 5. Patient preference dictates the choice between pharmacologic (less effective) and epidural blood patch (EBP). 6. In patients with severe symptoms, EBP is strongly suggested. 7. The most common pharmacologic measure is  caffeine  prescription. 8. The failure, worsening, or recurrence of symptoms after pharmacologic measures favors the use of EBP. 9. In addition to EBP, other epidural treatment options can be considered in select patients (eg,  dextran , saline). 10. A period of 24 h should lapse before repeating EBP. 11...
1 comment
Read more

Things to Avoid in Anesthesia for Pregnant with Pulmonary hypertension

Anesthesia for Pregnant woman with Pulmonary Hypertension is a real challenge for anesthesiologist. It is very crucial to remember the pathophysiology of pulmonary hypertension in pregnant women and to avoid some practices that will worsen the cardiac status. 1-Avoid single shot spinal anesthesia. Some authorities consider pulmonary hypertension as absolute contraindication for single shot spinal anesthesia specially in patients with NYHA III ,IV. Spinal anesthesia causes major hemodynamic instability(decrease SVR, decrease VR, decrease in CO) The preferred neuroaxial techniques are (epidural anesthesia and CSE with minimal spinal dose) 2-Avoid PAC. Pulmonary Artery catheters insertion may lead to pulmonary artery rupture or thrombosis. TEE is better cardiac monitor/Arteial line is mandatory. 3-Avoid Nitrous oxide in gas mixture.N2O increase the PVR 4-If MV to be started, avoid High TV and PEEP 5-Avoid Oxytocin Boluses, or rapid administration of Pitocin. Oxytocin causes ...
Post a Comment
Read more